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Introduction
The transition metal ion Zn 2ϩ , an essential cofactor for many enzymes and other proteins (Vallee and Falchuk, 1993) , has recently emerged as a possible cellular messenger in physiological and cytotoxic signaling (Bossy-Wetzel et al., 2004; Frederickson et al., 2005) . In the CNS, Zn 2ϩ is important for brain development, and the maintenance of an appropriate Zn 2ϩ concentration is critical to brain function. Moreover, exposure of neurons to excessive Zn 2ϩ can be toxic (Yokoyama et al., 1986) , inducing apoptosis at lower concentrations (Manev et al., 1997; Lobner et al., 2000) and necrosis at higher concentrations (Tonder et al., 1990; Choi and Koh, 1998) . A growing body of evidence also demonstrates Zn 2ϩ accumulation during oxygen and glucose deprivation (OGD), followed by reperfusion (Tonder et al., 1990; Koh et al., 1996; Snider et al., 2000; Lee et al., 2002; Wei et al., 2004) . The Zn 2ϩ chelating agent CaEDTA (Koh et al., 1996; Frederickson et al., 2002) and metal-binding proteins (van Lookeren Campagne et al., 1999) have been demonstrated to prevent the ischemia-induced injury. Ca 2ϩ plays an important role in the regulation of a variety of neuronal processes including excitability, associativity, neurotransmitter release, gene transcription, cell proliferation, and synaptic plasticity (Clapham, 1995; Berridge, 1998; Verkhratsky, 2005) . Many studies have implicated Ca 2ϩ as a mediator or trigger of neuronal damage and neurotoxicity. For example, the role of excessive Ca 2ϩ influx or Ca 2ϩ overloading in neuronal death after ischemic insults or brain trauma has been studied extensively (Benveniste et al., 1988; Paschen, 1996; Perez Velazquez et al., 1997; Nishizawa, 2001 ). Nevertheless, treatments or clinical drug trials designed to alter Ca 2ϩ influx or Ca 2ϩ homeostasis have met with limited success in reducing the volume or severity of neuronal damage (White et al., 1996; National Institute of Neurological Disorders and Stroke, 2002) .
Because much of the current knowledge about the roles of Ca 2ϩ elevation is derived from its interaction with fluorescent indicators, the evidence for increases in intracellular Zn 2ϩ during ischemic neural damage thereby poses a dilemma. This dilemma is particularly apparent when one considers that nearly all fluorescent Ca 2ϩ indicators also bind Zn 2ϩ with a high affinity (Grynkiewicz et al., 1985; Tsien and Pozzan, 1989) . In essence, the elevation of intracellular Zn 2ϩ may comprise part of, or the entirety of, conventionally measured intracellular Ca 2ϩ signals.
For example, although best known as an excitation wavelength ratiometric indicator for Ca 2ϩ , fura-2 is actually a 100-fold more sensitive as an indicator for Zn 2ϩ than Ca 2ϩ . The potential problems arising from such sensitivity of fluorescent indicators to Zn 2ϩ and of interference by Zn 2ϩ have been essentially ignored, attributable in part to the assumption that intracellular concentrations of Zn 2ϩ are very low (Haugland, 2001) . Here, we demonstrate that ischemia simulated by OGD, followed by reperfusion, result in an increase in [Zn 2ϩ ] i in global hippocampal slices. Furthermore, when a classic calcium indicator (Calcium Green-1) was used to monitor intracellular Ca 2ϩ rises, it turned out that a significant amount of the purported Ca 2ϩ fluorescent signal was actually caused by an elevation of Zn 2ϩ .
Materials and Methods
Preparations of brain slices and solutions. Male Sprague Dawley rats (200 -250 g) were anesthetized with ketamine HCl and decapitated; the brain was then quickly removed and submerged in ice-cold artificial CSF (ACSF). Coronal slices, 250 m in thickness, were made using a Vibratome (Series 3000 with 900R refrigeration; The Vibratome Company, St. Louis, MO). ACSF in the slicing chamber was kept ice cold and contained the following (in mM): 121 NaCl, 1.75 KCl, 5 MgCl 2 , 1.25 KH 2 PO 4 , 26 NaHCO 3 , and 10 glucose, gassed with 95%O 2 /5% CO 2 . After equilibrium, slices were transferred to a dye incubation chamber containing 2 ml of ACSF used in experiments (to which 2.5 mM CaCl 2 was added and MgCl 2 was 1.3 mM rather than 5 mM) at 32°C and bubbled with 95% O 2 /5% CO 2 . Care was taken to minimize potential Zn 2ϩ contamination (Martin et al., 2006) . All solutions were kept in Teflon bottles, and solutions/chemicals were transferred with metal-free pipette tips or spatulas coated with polymethylpentene. The testing buffer/solution was made with puriss grade salts [Sigma (St. Louis, MO) or Fluka (Neu-Ulm, Germany)] and, in some experiments (see Fig. 3 ), also stripped of divalent metal ions by treatment with Chelex-100 beads (5%; Bio-Rad, Richmond, CA).
Intracellular Zn 2ϩ measurements. To monitor intracellular Zn 2ϩ ([Zn 2ϩ ] i ), hippocampal slices were loaded with 10 M Newport Green (NG) DCF diacetate (excitation , 505 nm; emission , 535 nm) or 10 M Calcium Green-1 AM (excitation , 506 nm; emission , 531 nm) in 0.05% DMSO and 0.01 Pluronic F-127 from a 20% w/v stock solution of Pluronic F-127 dissolved in DMSO. Slices were maintained in the incubation chamber for 45 min at 32°C. Slices were then washed three times with ACSF and incubated for an additional 30 min in ACSF before imaging. All experiments were performed at 32°C, maintained at temperature with an SC-20 in-line heater equipped with a CL-100 temperature controller (Warner Instruments, Hamden, CT) under constant perfusion (2 ml/min) maintained by a Peristar peristaltic pump (World Precision Instruments, Sarasota, FL) in a 35 mm glass-bottomed chamber (MatTek, Ashland, MA) on the stage of an inverted laser-scanning confocal microscope (Axiovert LSM510; Zeiss, Oberkochen, Germany) or a Motic inverted microscope equipped with an Olympus (Tokyo, Japan) 10ϫ, 1.1 numerical aperture lens and a CCD camera (Retiga 1300i; QImaging, Burnaby, British Columbia, Canada). The images were digitized, and analysis was performed using Zeiss imaging software or ImagePro Plus software (Media Cybernetics, Silver Spring, MD).
OGD of slices. All oxygen-glucose-deprived slice manipulations were performed in 35 mm glass-bottomed chambers (MatTek) where slices were fully submerged in circulated oxygen-glucose-deprived ACSF and held in position using a circular platinum wire with a nylon grid that allowed for solution exchange. All solutions were prebubbled with either 95% O 2 /5% CO 2 or 95 N 2 /5% CO 2 gas for 30 min before slice immersion to ensure O 2 saturation or O 2 removal was achieved as desired. Baseline measurements were recorded for 10 -20 min before oxygen-glucosedeprived exposure. Oxygen-glucose-deprived exposure was implemented for 30 min, and slices were subsequently reperfused with normal ACSF for 40 min. N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), a membrane-permeable Zn 2ϩ chelator, was administered in the perfusate-ACSF at a concentration of 100 M during reperfusion as indicated.
Cell viability analysis. To analyze cell death resulting from ischemia and reperfusion and to assess the effect of [Zn 2ϩ ] i chelation on cell survival, slices were divided into three groups the same way in each of four iterations: control, ischemia, and ischemia with TPEN. After their respective treatments, as detailed below, slices were stained with propidium iodide (PI). The control groups were equilibrated and maintained in room-temperature ACSF bubbled with oxygen for 3 h. The ischemic groups were equilibrated in room-temperature ACSF for 30 min after slicing, subjected to 30 min oxygen-glucose-deprived insult, and reperfused in normal ACSF for 2 h. The TPEN/ischemia groups were equilibrated in room-temperature ACSF for 30 min, exposed to 100 M TPEN/oxygen-glucose-deprived ACSF for 30 min, and reperfused with 100 M TPEN/normal ACSF for 2 h. The implementation of a 2 h postinsult time duration was used to allow sufficient time for membrane damage to register and promote the detection of ischemically damaged cells by PI. PI staining was performed by incubating the sections with PI (5 g/ml in ACSF) for 30 min at room temperature after the respective treatments. PI fluorescence (excitation, 545 nm; emission, 645 nm) was analyzed and expressed as relative fluorescent intensity differences between experimental groups and control groups. PI fluorescence was recorded using a Zeiss Axiovert LSM 510 inverted microscope (laser scanning microscope). A one-way ANOVA was used to analyze the relative fluorescent intensity differences between the three groups tested, and a two-tailed t test was used as a test for significance (␣ ϭ 0.01).
Colocalization analysis. Colocalization of PI and NG staining was accomplished by performing two-channel laser scans of slices using confocal microscopy. A 488 nm krypton argon laser line was used for excitation of NG with a 505 nm emission filter. A 545 nm helium neon laser line with an excitation filter of 545 nm was used for excitation of PI with a 645 nm emission filter. After scanning, Zeiss imaging software produced single-channel results and a composite image compiled by fluorescent overlay. Colocalization experiments were conducted with minimal laser intensity and exposure time to minimize photobleaching.
Data analyses. For time-lapse ischemia experiments, baseline intensity was recorded and expressed as the mean stable fluorescence intensity of a slice region over the 10 -20 min period preceding oxygen-glucosedeprived perfusion. Background intensity was determined from tissuefree regions (i.e., next to the slice) in images, and this background was subtracted from baseline recordings. Oxygen-glucose-deprived and reperfusion-induced fluorescence change for each individual slice region was expressed as the change in fluorescence intensity relative to the baseline signal of each region. For time-lapse recordings, the effect of photobleaching was corrected by applying a least-squares curve-fit regression function derived from measurements of extended baseline slice behavior (data not shown) recorded from control experiments in which ischemia was not induced. Changes in cell fluorescence intensity were measured through simple two-group comparisons and analyzed by Student's paired t tests (␣ ϭ 0.05) or single-factor ANOVA.
Materials. The fluorescent dyes Calcium Green-1 AM, NG DCF diacetate, TPEN, and Pluronic F-127 (20% w/v in DMSO) were obtained from Invitrogen (Carlsbad, CA). All other chemicals were obtained from Sigma or Fluka.
Results

Intracellular Zn
2؉ transients during ischemia, as simulated by OGD and reperfusion Intracellular Zn 2ϩ elevation during OGD and reperfusion In this study, we loaded hippocampal slices with the Zn 2ϩ -selective fluorescent indicator NG diacetate ester to determine and to characterize increases in intracellular Zn 2ϩ . Another reason for choosing NG for this study is that its fluorescence is not appreciable in the presence of physiological levels of Ca 2ϩ and Mg 2ϩ (Canzoniero et al., 1999; Li et al., 2001a,b; Martin et al., 2006) . This property in a Zn 2ϩ indicator is critical for this experiment, particularly in differentiating Zn 2ϩ signals from Ca 2ϩ signals. The CA1 region of the hippocampus was chosen as the region of interest because of its increased vulnerability to ischemic damage when compared with other regions and because it has been studied extensively. After recording baseline fluorescence, hippocampal slices were subjected to 30 min of OGD. A duration of 30 min OGD was chosen because [Zn 2ϩ ] i reached a maximum concentration after a prolonged exposure of 30 -40 min (Wei et al., 2004) . The oxygen-glucose-deprived exposures were followed by reperfusion with normal oxygenated ACSF. The data indicated gradual increases in [Zn 2ϩ ] i with increasing oxygen-glucose-deprived time. Subsequent reperfusion resulted in an additional increase in intracellular Zn 2ϩ (Fig. 1) . The amplitudes of fluorescence intensity were depicted in arbitrary units, and were measured from the baseline to the peak of fluorescent responses. The amplitudes were 6.6 Ϯ 1.1 (mean Ϯ SE) in OGD and 16.3 Ϯ 1.7 (mean Ϯ SE) in reperfusion; fluorescent values were significantly higher in reperfusion ( p Ͻ 0.01; n ϭ 10). Figure 2 shows evidence that nitric oxide (NO) can induce accumulation of [Zn 2ϩ ] i . The application of the NO donor ( Fig. 2 A, C), spermine-NONOate, released exogenous NO and resulted in Zn 2ϩ -specific fluorescence increase. When 500 M spermine-NONOate was dissolved, NO was liberated in a timedependent manner (5-10 min.), leaving the polyamine, spermine, as a by-product. Control tests were done with spermine (500 M, 20 min) to ensure that the Zn 2ϩ release by spermineNONOate resulted from the action of NO itself, and not a property of the polyamine remaining after the liberation of NO. There was no change of NG fluorescence in control hippocampal slices incubated in the presence or in the absence of spermine (Fig.  2 B, D) . Spermine-NONOate produced a significant enhancement in [Zn 2ϩ ] i detected with NG, suggesting a mechanism for the regulation of Zn 2ϩ homeostasis under OGD and reperfusion. These data support NO as a causal agent in the fluorescence changes, as has been documented previously (Cuajungco and Lees, 1998; Frederickson et al., 2002; Bossy-Wetzel et al., 2004) . Furthermore, these results support the previous observation that the NO synthase inhibitor L-NAME inhibited 60 -70% of the accumulation of Zn 2ϩ in both OGD and reperfusion (Wei et al., 2004 (Grynkiewicz et al., 1985; Tsien and Pozzan, 1989) , it has been assumed that the presence of physiologically relevant Ca 2ϩ in the sample will prevent Zn 2ϩ from binding to fluorescent Ca 2ϩ indicators, possibly by surrounding the indicator with a sufficient number of Ca 2ϩ molecules. We investigated metal ion responses by screening Calcium Green-1 for Zn 2ϩ in physiological solutions containing various metal ion concentrations (Martin et al., 2006) . We also studied Zn 2ϩ selectivity over Ca 2ϩ by the measurement of Zn 2ϩ responses in the presence of a relatively large Ca 2ϩ concentration. Even when saturating the probe with Ca 2ϩ before the addition of Zn 2ϩ , the indicator continued to report zinc concentrations with fidelity. Our recent work (Martin et al., 2006) shows how Calcium Green-1, a widely used fluorescent calcium indicator, was still capable of detecting Zn 2ϩ in the presence of a physiologically relevant Ca 2ϩ concentration (2 mM). In these experiments, the baseline fluorescence was set after the addition of Ca 2ϩ and was readjusted before adding ] i increase during OGD and reperfusion. A, Images of the CA1 region of a hippocampal slice preloaded with NG diacetate ester as described in Materials and Methods. The fluorescence intensities of CA1 pyramidal cells were examined for at least 10 min before (1), during (2), and after (3) perfusion with oxygen-glucose-deprived ACSF bubbled with 95% N 2 /5% CO 2 . The oxygen-glucose-deprived insult was administered for 30 min, and the slice was reperfused with normal oxygenated ACSF for 40 min. Images 1-3 are pseudocolor images of images 1-3. Scale bars, 100 m. B, A representative graph shows the measured change of NG fluorescence intensity, indicating increases in intracellular Zn 2ϩ during the course of OGD and reperfusion. Arrows show the start of OGD-simulated ischemia and reperfusion, respectively. The y-axis represents the fluorescence emission intensity of the dye/ ion complex in arbitrary units.
Nitric oxide induced the increase in [Zn 2ϩ ] i in neurons
binding dynamics of the indicator (data not shown). Our model showed that additional coordination of a Zn 2ϩ ion to the carboxylate oxygen and the amide carbonyl on the central ring of the indicator may occur even when Ca 2ϩ is already bound. Such binding created a Zn 2ϩ -carboxylate in the syn configuration, the dominant mode of bonding interaction seen in carboxylate metal-ligand interaction (Holm et al., 1996) . The second bond interaction through the amide carbonyl oxygen atom is in agreement with sites of amide-metal ion coordination in many proteins (Holm et al., 1996) . In this model, the bond distance is 2.51 Å, which is greater than the average Zn-donor atom distance, although 2.5 Å is considered the average bond distance for Zn-O Glutamate interaction (Hammes and Carrano, 1999) . This bond distance of 2.51 Å is also seen in the transition state of farnesyltransferase, a zinc metalloenzyme (Sousa et al., 2005) . All molecular calculations were performed using ArgusLab 4.0 (Planaria Software, Seattle, WA).
Fluorescent Ca 2ϩ probe detecting cellular Zn 2ϩ
Next, we studied whether a commonly used fluorescent Ca 2ϩ indicator such as Calcium Green-1 can detect Zn 2ϩ in situ. To test this speculation, cultured neurons were preloaded with Calcium Green-1 AM and placed in a recording chamber on the microscope stage with continuous perfusion of ACSF (without added Ca 2ϩ ). To investigate whether Zn 2ϩ can be detected in situ with a fluorescent Ca 2ϩ probe, 300 M Zn 2ϩ and 100 M Napyrithione, a Zn 2ϩ ionophore that facilitates ion influx into cells, were added to the perfusate. In the presence of Zn 2ϩ alone, minimal change of intracellular fluorescence of Calcium Green-1 was observed (Fig. 3B) (Frederickson et al., 2005) (Fig. 1) . When the hippocampal slice was loaded with cell-permeable Calcium Green-1, as expected, a steady increase in fluorescence intensity was detected during OGD and reperfusion (Fig.  4) . Because Calcium Green-1 is also sensitive to Zn 2ϩ , as indicated above, we examined the extent to which Zn 2ϩ signals contributed to the Ca 2ϩ signal. The zinc chelator TPEN was then added at the peak of the fluorescence intensity to reveal the Zn 2ϩ signal component. In these experiments, the addition of TPEN after reperfusion with normal ACSF reduced the amplitude of Calcium Green-1 fluorescence. The peak fluorescence intensity in arbitrary units was 10.3 Ϯ 2.03 (mean Ϯ SE) in OGD, 16.78 Ϯ 2.78 (mean Ϯ SE) in reperfusion, and 4.44 Ϯ 2.52 (mean Ϯ SE) in TPEN ( p Ͻ 0.01 compared with baseline value; n ϭ 9). TPEN did not always diminish the fluorescence to the baseline value. The remaining fluorescence in the presence of TPEN may be the Ca 2ϩ component. These data show that Zn 2ϩ ions contribute significantly to rising fluorescence intensity measured with Ca 2ϩ indicators in OGD and reperfusion.
Elevated Zn
2؉ is a major factor in neuronal cell death during ischemic stroke TPEN prevents pyramidal neurons from sustaining ischemic damage We examined the extent of CA1 pyramidal neuronal injury resultant after oxygen-glucose-deprived exposure. These experiments used the fluorescent cell-death marker PI to assess injury. PI is a cell membrane-impermeant dye that becomes brightly fluorescent after binding to DNA in dead cells. It enters injured neurons in which the plasma membrane is disrupted and is shown to preferentially accumulate in the nucleus of dying neurons. Hippocampal slices were grouped into control (incubation with normal ACSF), OGD/reperfusion (30 min OGD), and TPEN-treated groups. After OGD, the slices were incubated for 2 h in oxygenated media. In the TPEN treatment groups, TPEN was present in the perfusate of OGD and reperfusion and was then withdrawn from ACSF 30 min after reperfusion. The slices in the control groups were incubated in normal ACSF for the same time duration as both of the other groups. PI was added during the final 30 min of the incubation, followed by fixation and subsequent visualization of PI fluorescence using confocal microscopy. Images were obtained deep (75-100 m) within the slice, where injury resulting from the trauma of slicing is minimized. A set of examinations was stopped if Ͼ5% of cells stained in the control slice. Figure 5 shows that little PI fluorescence was seen in pyramidal cell layers of the control group, but a strong signal was present in the OGD/reperfusion group. Subsequent experiments examined the effect of TPEN on the extent of pyramidal neuronal injury resulting from oxygen-glucose-deprived exposure. PI labeling was decreased significantly ( p Ͻ 0.05; n ϭ 6 slices per group) by TPEN. Post hoc analysis using the Bonferroni method showed the ischemia group to be different from the TPEN and control groups (95% confidence level). Expressed as percentage difference of fluorescence intensity from control (control intensity considered to be 1.0, or 100%), the OGD/ reperfusion group was measured at 2.07 times higher average fluorescence or 207% of control, and the TPEN treatment during OGD/reperfusion was measured at 1.22 times average higher fluorescence or 122% of control. These observations indicate that the Zn 2ϩ buildup in pyramidal neurons during OGD and reperfusion is a causal factor in the resultant ischemic injury. Furthermore, the removal of [Zn 2ϩ ] i by chelation prevents pyramidal neurons from sustaining extensive ischemic damage. [Zn 2ϩ ] i and neuronal cell death In a separate experiment, cell viability was comparatively determined with dual staining of PI and cell-impermeant NG in hippocampal slices that were subjected to OGD/reperfusion. When viewed using a fluorescence microscope (645 nm filter), cells that lost membrane integrity showed contrasting red PI staining throughout the nuclei (Fig. 6 A) in the same tissue sections that also stained initially with cell-impermeant NG (Fig. 6 B) . Therefore, the dual fluorescent staining, or colocalization, of PI and NG staining showed agreement between endogenous increases in [Zn 2ϩ ] i and indications of neuronal damage ( Fig. 6C) with Pearson's correlation coefficient r ϭ .743 (n ϭ 28) . These data suggested that cells labeled with NG were damaged and becoming necrotic or undergoing apoptotic cell death. Signal overlap was ruled out as a factor responsible for the higher intensity of NG nuclear fluorescence by examining slices stained only with PI and performing scans using the same NG examination parameters as during colocalization experiments; results showed only minimal background intensity. Conversely, using excitation and emission wavelengths for NG, we did not observe PI staining (data not shown) in slices stained only with PI.
Colocalization of the increase in
Discussion
First, our results indicate that there is a rapid Zn 2ϩ accumulation in acute rat hippocampus slices during OGD and reperfusion, which demonstrates that the divalent cation Zn 2ϩ accumulates in concomitance with cerebral ischemic insults. The second, and major, finding is that intracellular Zn 2ϩ elevation can contribute to signals previously interpreted as Ca 2ϩ overload conventionally identified by using "Ca 2ϩ -specific" fluorescent indicators. Finally, the progressive rise in [Zn 2ϩ ] i levels during ischemic insult corresponds with neuronal death in the hippocampal slice, and Zn 2ϩ chelation prevents hippocampal neurons from developing injury during OGD/reperfusion.
Fluorescent Ca
2؉ probes Most of these fluorescent indicators are derivatives of the Ca 2ϩ chelators BAPTA, EGTA, and aminophenol triacetic acid (APTRA) (Tsien and Pozzan, 1989; Haugland, 2001) , which also bind Zn 2ϩ with significantly higher affinity. The K D values of BAPTA are as follows (Grynkiewicz et al., 1985; Haugland, 2001 indicators with substantially higher affinity than Ca 2ϩ . Calcium Green-1, a widely used Ca 2ϩ indicator, uses the BAPTA chelator motif, which is shown to bind Zn 2ϩ with a K D that is nearly two orders of magnitude lower (higher affinity) than that of Ca 2ϩ (see above). As another example, the ubiquitous Ca 2ϩ indicator fura-2 exhibits a K D for Zn 2ϩ (in the absence of Ca 2ϩ ) of 3 nM (Grynkiewicz et al., 1985; Haugland, 2001) .
We have tested the responses of BAPTA-based Ca 2ϩ indicators, including Calcium Green-1, fluo-3, and fura-2 to a series of concentrations of Ca 2ϩ or Zn 2ϩ in a physiological saline (ACSF). All three probes showed an affinity for both Ca 2ϩ and Zn 2ϩ , and the response curves representing detection parameters for each divalent ion were very similar (Martin et al., 2006) . Fura-2, because of its sensitivity to Zn 2ϩ , has even been used to detect intracellular Zn 2ϩ influx via voltage-gated Ca 2ϩ channels (Atar et al., 1995; Aizenman et al., 2000) . Although it has been recognized that most Ca 2ϩ indicators have a higher affinity toward Zn 2ϩ rather than Ca 2ϩ , it has been assumed that the presence of physiologically relevant Ca 2ϩ in the sample will prevent Zn 2ϩ from binding to fluorescent Ca 2ϩ indicators, possibly by surrounding the indicator with a sufficient number of molecules of Ca 2ϩ . As our previous experiments showed, not only are these fluorescent Ca 2ϩ probes sensitive to Zn 2ϩ , but the presence of physiologically relevant Ca 2ϩ minimally perturbs their response to Zn 2ϩ (Martin et al., 2006) . The evidence clearly supports the use of such probes as effective and efficient Zn 2ϩ indicators. Results such as these reinforce the necessity for a reanalysis of the evidence in which the ionic identities responsible for Ca 2ϩ signals under conditions in which causality has been derived from the detection of Ca 2ϩ by fluorescent indicators. The binding affinities of Ca 2ϩ and Zn 2ϩ for Calcium Green-1 may be a critical factor in interpreting the data presented in this study. Evidence on the binding activity of 5-F-BAPTA (a chelator very closely related to the BAPTA group of Calcium Green-1) presented by Csermely et al. (1989) describes a large difference in the binding lifetimes of Zn 2ϩ and Ca 2ϩ . They found that Ca 2ϩ binding occurs with a lifetime of ϳ5 ms, whereas it was found that Zn 2ϩ -binding lifetimes lasted approximately five to six times longer, ϳ32 ms (Csermely et al., 1989) . Considering that the energy transitions that produce fluorescence occur when the fluorophore is in the bound state, and that photons are produced during a given binding according to duration of binding, the much longer lifetime of a Zn 2ϩ -Calcium Green-1 complex would be expected to result in an increased photon emission for a given binding event and would necessarily be interpreted as an increased intensity of emission. Second, our molecular modeling indicates the possibility of an alternate Zn 2ϩ -binding mechanism occurring when Calcium Green-1 is already bound to Ca 2ϩ (see Results). probes such as fura-2 and Calcium Green-1 has been reported in detail previously (Grynkiewicz et al., 1985; Tsien and Pozzan, 1989) , the information concerning Zn 2ϩ sensitivity has essentially been ignored. This has led to the status quo, in which Zn 2ϩ has received comparatively far less study in physiological systems. It has been believed that intracellular concentrations of Zn 2ϩ , a trace element in the biological system, are very low (Haugland, 2001 could, in part, be attributed to Zn 2ϩ , then the "calcium overload" that has been described in the past, using Ca 2ϩ -sensitive indicators, needs to be re-examined to determine whether Ca 2ϩ signals are, in fact, a cause of neuronal damage. Such evidence shows the urgent need for the development of truly selective fluorescent Ca 2ϩ indicators, which we consider integral to furthering the understanding of the role that Ca 2ϩ plays in cellular signaling and pathology.
Zn
Zinc homeostasis
It is well known that 85-90% of Zn 2ϩ in the body is tightly bound to proteins and is composed mostly of metalloenzyme-and metalloprotein-bound zinc (Choi and Koh, 1998) . Metallothioneins can serve as intracellular reservoirs for release of Zn 2ϩ during signaling or during deficiency states. Recently, evidence from our group and others suggested that the reactive-free radical species NO may be involved in the regulation of Zn 2ϩ homeostasis (Cuajungco and Lees, 1998; Snider et al., 2000; Frederickson et al., 2002; St Croix et al., 2002; Bossy-Wetzel et al., 2004; Wei et al., 2004; Zhang et al., 2004) . In particular, results in which the NO synthase inhibitor L-NAME reduced 60 -70% of the accumulation of Zn 2ϩ in both OGD and reperfusion (Wei et al., 2004 ) show significant support for this theory. Additionally, the present study shows that NO directly liberates Zn 2ϩ from its intracellular stores (Fig. 2) . The mechanism of NO-mediated Zn 2ϩ release is not entirely understood, but evidence points toward a release from metallothionein and zinc-finger proteins by S-nitrosylation of cysteine clusters that bind Zn 2ϩ (Aravindakumar et al., 1999; Maret et al., 1999; Hong and Maret, 2003) . In addition to metallothioneins, Zn 2ϩ can be also released from a specific subset of glutamatergic nerve terminals throughout the mammalian cortex of the brain. The released Zn 2ϩ has been shown to then translocate into postsynaptic neurons through Zn 2ϩ -permeable channels (Li et al., 2001b (Li et al., , 2003 , thereby creating a [Zn 2ϩ ] i transient. Free intracellular Zn 2ϩ can produce mitochondrial membrane permeability transitions, inhibit respiratory complex I, and cause cytochrome c release (considered a critical step leading toward apoptosis) (Noh et al., 1999; Truong-Tran et al., 2001; Dineley et al., 2003; Bossy-Wetzel et al., 2004) . Because it is well known that NO is generated during ischemia and reperfusion (Beckman, 1991; Moncada and Higgs, 1993; Dawson and Dawson, 2000) , these results suggest that NO may be involved in the release of Zn 2ϩ during ischemia and reperfusion.
Conclusion
It is known that changes in ionic concentration have a fundamental effect on numerous physiological processes related to brain function. Given the results presented in this study, we are convinced that only when truly selective Ca 2ϩ probes are developed can investigators unmitigatingly define the role of Ca 2ϩ signaling in biological processes. On the other hand, the indications that both Zn 2ϩ and Ca 2ϩ appear to be overloaded in ischemic conditions should compel more studies to address the distinctions between Zn 2ϩ and Ca 2ϩ . Are there redundant roles and/or separable roles for Ca 2ϩ and Zn 2ϩ , and what are these specific functions? We hope that additional investigations with the current results in mind can lead to the realignment of current thinking and the production of a workable ischemic therapy.
